Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
US to re-engage with Gavi vaccine alliance amid Ebola outbreak
Iran studying deal to halt war as stalemate persists
WHO says suspected Ebola cases drop to 116 after hundreds ruled out
Israel strikes south Lebanon after holding off Beirut attack
At least 22 killed in heavy Russian attack on Ukrainian cities
